HomeNSB • ASX
add
Neuroscientific Biopharmaceuticals Ltd
Nakaraang pagsara
$0.038
Sakop ng araw
$0.038 - $0.038
Sakop ng taon
$0.033 - $0.078
Market cap
4.95M AUD
Average na Volume
204.08K
P/E ratio
16.96
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 47.57K | — |
Gastos sa pagpapatakbo | 230.14K | -64.85% |
Net na kita | -183.78K | 70.12% |
Net profit margin | -386.31 | — |
Kita sa bawat share | — | — |
EBITDA | -159.80K | 74.81% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 4.49M | 34.67% |
Kabuuang asset | 5.01M | 27.50% |
Kabuuang sagutin | 26.00K | -77.97% |
Kabuuang equity | 4.98M | — |
Natitirang share | 147.02M | — |
Presyo para makapag-book | 1.27 | — |
Return on assets | -9.11% | — |
Return on capital | -9.16% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -183.78K | 70.12% |
Cash mula sa mga operasyon | -230.39K | 70.71% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | -230.39K | 70.75% |
Malayang cash flow | -92.10K | 72.92% |
Tungkol
Itinatag
2002
Website
